Internal Medicine Alert – September 30, 2006
September 30, 2006
View Issues
-
Finally an Optimal Strategy for Diagnosing Deep Vein Thrombosis
A medical research unit in the United Kingdom analyzed 18 different strategies for managing patients with suspected deep vein thrombosis (DVT). Using systematic review, meta-analysis and cost effectiveness analysis, they settled on an algorithm based on clinical risk. -
Esomeprazole 40 mg Once a Day in Patients with Functional Dyspepsia
Functional dyspepsia cannot reliably be diagnosed using symptoms alone. Esomeprazole therapy is not effective vs placebo in an 8-week study of endoscopy-negative patients with histories thought to be diagnostic of FD. -
Oral Anticoagulation for Stroke Prevention in AF
Warfarin remains superior to antiplatelet agents for stroke prevention in patients with AF. -
Does HCV Really Go Away?
HCV may persist and replicate in the liver and PBMCs of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients who have persistently normal ALT levels. These patients should be followed up, because they have an ongoing viral infection. -
Antibiotics for Acute Purulent Rhinitis? 'S not a Good Idea
Antibiotics may improve acute purulent rhinitis at the cost of gastrointestinal upset and rash. -
Efavirenz/Emtricitabine/Tenofovir Tablets (Atripla™)
The FDA has approved the first, one tablet, once-daily, three-drug combination for the treatment of HIV-1 infections. -
Clinical Briefs By Louis Kuritzky, MD
Tight glucose control has been shown to provide improved outcomes in both Type 1 and Type 2 diabetes (DM2).